Keenova Therapeutics plc - Company Profile and SWOT Analysis

May 2026 | 45 pages | ID: MDA392D64E4EN
MarketLine

Abstracts

Summary

Keenova Therapeutics plc - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Keenova Therapeutics plc (Keenova) formerly Mallinckrodt Plc, is a specialty biopharmaceutical company. It develops, manufactures, markets, and distributes specialty pharmaceuticals and therapies under the brands Acthar, StrataGraft, Inomax, Therakos, Terlivaz, and Amitiza. It markets branded pharmaceutical products for nephrology, rheumatology, neurology, pulmonology and ophthalmology. The company also markets drugs that include a variety of product formulations and provides bulk active pharmaceutical ingredients products. Keenova sells its branded medicines straight to doctors, specialty drug providers, hospitals, and outpatient surgery clinics, and it also supplies both branded and non-branded medicines through a broad channel of medication wholesalers, specialty distribution partners, and retail pharmacy groups, among other outlets. The Company operates sites across the US, Ireland, Japan, and other international locations. Keenova is headquartered in Blanchardstown, Dublin, Ireland.

Scope

• Detailed information on Keenova Therapeutics plc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Keenova Therapeutics plc in the form of a SWOT analysis
• An in-depth view of the business model of Keenova Therapeutics plc including a breakdown and examination of key business segments
• Intelligence on Keenova Therapeutics plc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Keenova Therapeutics plc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Keenova Therapeutics plc and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Keenova Therapeutics plc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Keenova Therapeutics plc's business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
Keenova Therapeutics plc: Company Overview
Keenova Therapeutics plc: Overview and Key Facts
Keenova Therapeutics plc: Overview
Keenova Therapeutics plc: Key Facts
Keenova Therapeutics plc: Key Employees
Keenova Therapeutics plc: Key Employee Biographies
Keenova Therapeutics plc: Major Products and Services
Keenova Therapeutics plc: Management Statement
Keenova Therapeutics plc: Locations and Subsidiaries
Keenova Therapeutics plc: Key Competitors
Keenova Therapeutics plc: Company Analysis
Keenova Therapeutics plc: Business Description
Keenova Therapeutics plc: SWOT Analysis
Keenova Therapeutics plc: SWOT Overview
Keenova Therapeutics plc: Strengths
Keenova Therapeutics plc: Weaknesses
Keenova Therapeutics plc: Opportunities
Keenova Therapeutics plc: Threats
Keenova Therapeutics plc: Corporate Financial Deals Activity
Keenova Therapeutics plc: Financial Deals Overview
Keenova Therapeutics plc: Targets and Partners
Keenova Therapeutics plc: Top Deals 2022 - 2026YTD*
Keenova Therapeutics plc: Advisors
Keenova Therapeutics plc: Top Legal Advisors
Keenova Therapeutics plc: Top Financial Advisors
Keenova Therapeutics plc: Mergers and Acquisitions
Keenova Therapeutics plc: Partnership
Keenova Therapeutics plc: Divestments
Keenova Therapeutics plc: Private Equity and Ownership
Keenova Therapeutics plc: Recent Developments
Keenova Therapeutics plc: News and Events Summary
Keenova Therapeutics plc: Business Expansion
Keenova Therapeutics plc: Corporate Governance
Keenova Therapeutics plc: Financial Deals
Keenova Therapeutics plc: Financial Performance
Keenova Therapeutics plc: Market Developments
Keenova Therapeutics plc: Research & Development
Keenova Therapeutics plc: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Keenova Therapeutics plc: Key Facts
Table 2: Keenova Therapeutics plc: Key Employees
Table 3: Keenova Therapeutics plc: Locations and Subsidiaries
Table 4: Keenova Therapeutics plc: Key Competitors
Table 5: Keenova Therapeutics plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Keenova Therapeutics plc: M&A Activity by Geography (TTM*)
Table 7: Keenova Therapeutics plc: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Table 8: Keenova Therapeutics plc: M&A Average Deal Size - Value (US$m)
Table 9: Keenova Therapeutics plc: Targets and Partners
Table 10: Keenova Therapeutics plc: Top Deals 2022 - 2026YTD*
Table 11: Keenova Therapeutics plc: Legal Advisor Ranking by Value (US$m)
Table 12: Keenova Therapeutics plc: Financial Advisor Ranking by Value (US$m)
Table 13: Keenova Therapeutics plc: M&A Volume and Value Trend (2022 - YTD*2026)
Table 14: Keenova Therapeutics plc: Partnership Volume and Value Trend (2022 - YTD*2026)
Table 15: Keenova Therapeutics plc: Divestments Volume and Value Trend (2022 - YTD*2026)
Table 16: Keenova Therapeutics plc: Private Equity and Ownership Volume and Value Trend (2022 - YTD*2026)
Table 17: Keenova Therapeutics plc: Private Equity and Ownership Volume by Deal Type (2022 - YTD*2026)
Table 18: Keenova Therapeutics plc: News and Events Summary
Table 19: Keenova Therapeutics plc: Business Expansion
Table 20: Keenova Therapeutics plc: Corporate Governance
Table 21: Keenova Therapeutics plc: Financial Deals
Table 22: Keenova Therapeutics plc: Financial Performance
Table 23: Keenova Therapeutics plc: Market Developments
Table 24: Keenova Therapeutics plc: Research & Development
Table 25: Keenova Therapeutics plc: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: Keenova Therapeutics plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Keenova Therapeutics plc: M&A Activity by Geography (TTM*)
Figure 3: Keenova Therapeutics plc: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Figure 4: Keenova Therapeutics plc: M&A Average Deal Size - Value (US$m)
Figure 5: Keenova Therapeutics plc: M&A Volume and Value Trend (2022 - YTD*2026)
Figure 6: Keenova Therapeutics plc: Partnership Volume and Value Trend (2022 - YTD*2026)
Figure 7: Keenova Therapeutics plc: Divestments Volume and Value Trend (2022 - YTD*2026)
Figure 8: Keenova Therapeutics plc: Private Equity and Ownership Volume and Value Trend (2022 - YTD*2026)
Figure 9: Keenova Therapeutics plc: Private Equity and Ownership Volume by Deal Type (2022 - YTD*2026)